WHO WE ARE

The INNODIA People with T1D Community (INPACT) stands as a group of informed, trained, and motivated individuals, either living with Type 1 Diabetes (T1D) themselves or navigating the journey alongside family members. We are people ardently working to expedite medicine development aimed at curing T1D.
We represent not just a voice, but the collective expectations and aspirations of people with T1D within INNODIA.

INNODIA is an international non-profit organization that functions as interface between those who want to develop new disease modifying (DM) therapies for T1D and those who have the expertise and tools to do so.
INNODIA catalyzes, in a comprehensive and efficient way, entities that have often different incentives but who want to address the same unmet medical need: the lack of definitive cures for T1D. Importantly, INNODIA wants to provide to medicine-developers the adequate support to design their patientcentric products, understand the patient/clinician relationship, and make patient-informed business decisions.

The perspective of patients and families are central in INNODIA with the goal to make this voice broader, united and better informed.

The concept at the heart of INPACT is to bring together a community of people living with T1D representing all possible ages, genders, ethnicities, ages at disease onset, types of disease management, countries of residency etc..

All individuals who want to enter the community will be asked to develop a basic set of competencies and, once reached, they will become Certified INPACT Associates, who will be steered by INPACT Leads living in their countries. All INPACT Associates will be engaged in activities instrumental to INNODIA mission such as: advise medicine developers, support clinical sites, engage with local communities to share knowledge and the most recent advancements in the field of T1D, raise funds for specific INNODIA projects, etc.

OUR VISION

We strive for a world without T1D, and achieve this together with the voices, actions, and the strength of the people living with the disease and their care givers.

OUR MISSION

We make every effort to accelerate the development of new cures and promote disease modifying therapies for PwD, everywhere, through the voices of the community of people living with T1D and their care givers.

OUR CORE VALUES

  • COURAGE to raise our voices to influence the outcome of medicine development and to be engaged on the frontline

  • INCLUSION by ensuring diverse representation of people with T1D within INPACT and inside all INNODIA activities

  • EXCELLENCE by providing a continuous and focused training to all INPACT Associates

  • TRANSPARENCY by openly sharing our processes and outcomes

  • RESILIENCE to not get discouraged by the inevitable challenges we’ll meet

  • PASSION in what we do, day by day

OUR OBJECTIVES

  • Influence Medicine Development Processes
    Ensure that research and clinical trials are patient-centric and address the needs and concerns of the T1D community

  • Support
    Provide support to patients, their families, and all the stakeholders through resources, information and community building

  • Awareness
    Raise awareness about INNODIA in and among people with T1D, focusing on the need to be involved since the beginning of the medicine development processes.

  • Steer
    Ensure that INNODIA remains focused and stays loyal to the principle of Patient Centricity

OUR STRATEGIES

Build a large community of people living with T1D all over Europe and enhance the capacity of INPACT Associates through training and access to relevant information and resources

Engage with people living with T1D and their care givers on a regular basis to gather insights, experiences, and feedback

Develop partnerships with other organizations, researchers and stakeholders to enhance the reach and impact of INNODIA

Establish effective communication channels between INPACT, INNODIA, and medicine developers

Cures - Faster - Together